<DOC>
	<DOC>NCT00723346</DOC>
	<brief_summary>Primary objective : - To explore the relation between 3 doses of GRASPA and duration of asparagine depletion (&lt; 2Âµmol/l) Secondary objective : - Pharmacokinetic / Pharmacodynamic parameters - toxicity - Study duration : 2 years - Study treatment : Red blood cells loaded with L asparaginase versus native L asparaginase - Associated treatments : COPRALL chemotherapy - Randomization : centralised randomisation on scratching list</brief_summary>
	<brief_title>Administration of Allogenic Red Blood Cells Loaded L-asparaginase in Cases of Relapse of Acute Lymphoblastic Leukaemia</brief_title>
	<detailed_description />
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Precursor Cell Lymphoblastic Leukemia-Lymphoma</mesh_term>
	<mesh_term>Leukemia, Lymphoid</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Asparaginase</mesh_term>
	<criteria>Subject between 1 and 55 year old Subject with acute lymphoblastic leukaemia or lymphoblastic lymphoma (excluded burkitt lymphoma) who have relapsed after first remission (medullary or SNC relapse) Or patient who still refractory to first line chemotherapy for an ALL Patient who gave written informed consent (2 parents for children)</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2012</verification_date>
	<keyword>Relapse</keyword>
	<keyword>Lymphoma lymphoblastic</keyword>
</DOC>